Amicrobe Revenue and Competitors

Amicrobe is developing a new generation of locally applied products to prevent and treat life-threatening infections. Our powerful technology platform, called Amicidins™, brings the upside potential of breakthrough biotech products with the reduced commercial risk of multi-use materials. Amicidins are synthetic proteins engineered for local application. They combine beneficial physical properties and microbicidal activity against an array of pathogens. When directly applied to vulnerable tissues “inside the body”, Amicidins can block contamination before it occurs or treat contamination/infection to help stop disease progression.